Found: 1
Select item for more details and to access through your institution.
A Phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease.
- Published in:
- 2001
- By:
- Publication type:
- journal article